Company
iVEAcare
IVEAcare is developing innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations.
Also known as iVEAcare, Inc.
- Business model
- B2B
- Legal name
- iVEAcare, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
iVEAcare is developing next-generation neuromodulation therapies using advanced implantable devices and software
Funding snapshot
- Total raised
- $15.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series A, $27.5M2024-04-22
Funding rounds
- Series A
- $27.5M2024-04-22, Company stated
- Round, 2024
- $15.5M2024-04-12, SEC form D sold, 5 investors
About the company
- Status notes
- privately held, development stage medical device company
Loading relationship preview